Dear Sir/ Madam, Pursuant to Regulation 57(4) of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements), Regulations, 2015 (LODR), please find the attached intimation. You are requested to kindly take the same on record and oblige. Thanking you.

PRISM MEDICO AND PHARMACY LIMITED CIN: L24100HP2002PLC009299; Email Id: investorgrievancewmcl@gmail.com Registered Office: Suketi Road, Kala Amb, Sirmaur, Himachal Pradesh-173030 Date: 30/09/2026 To, T o, Department of Corporate Services, Listing Department, BSE LIMITED Metropolitan Stock Exchange of India Limited P, J. Towers, Daial Street, (MSED . Mumbai, Maharashtra-400001. Vibgyor Towers, 4‘ Floor, Plot Number C 62, G - Block, Opposite Trident Hotel, Bandra Kurla Complex, ISIN: INE730E01016 Bandra (E), Mumbai, Maharashtra-400098. Scrip Code: 512217 SYMBOL: PRISMMEDI Subject: Intimation under Regulation 57(4) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir / Madam, Pursuant to Regulation 57(4) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR), it is informed that the company has not issued any non-convertible securities for which interest/dividend/principal amount shall be payable during the quarter begining from 01st October, 2026 and ending on 31st December, 2026. You are requested to kindly take the same on your record and acknowledge receipt. Thanking You. Yours Truly, FOR pesy MEDICO AND PHARMACY LIMITED Tyo Hf DAVEN DER SINGH DIRECTOR | DIN: 09447213.